Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Institute for Biomarker Research, |
RCV003482216 | SCV004228088 | likely benign | Hereditary cancer-predisposing syndrome | 2023-08-04 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003779219 | SCV004576503 | likely benign | Familial cancer of breast; Fanconi anemia complementation group J | 2023-12-26 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003482216 | SCV005029346 | likely benign | Hereditary cancer-predisposing syndrome | 2023-09-21 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |